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Introduction:
Elevated serum uric acid (UA) in humans often stems from the consumption of an enriched, socalled Westernized diet coupled with the lack of a functional urate oxidase gene (Uro). Such elevated UA levels in the blood (hyperuricemia) or urine (hyperuricosuria) are key risk factors for gout and kidney stones, respectively (Kuo et al., 2015; Zhu et al., 2012) . Gout, which affects nearly 4% of the US population, often presents with acute arthritis that is caused by a buildup of UA crystals, typically in the metatarsal-phalangeal joint space (Fisher et al., 2014; Kuo et al., 2015) . Patients with urinary stone disease often show elevated UA levels as well. More broadly, hyperuricemia affects over 20% of the US population and has been associated with hypertension, dyslipidemia, kidney disease, type 2 diabetes, premature death, and higher allcause mortality risk (Barron et al., 2015; Fisher et al., 2017; Giordano et al., 2015; Kanbay et al., 2016; Kuwabara, 2016; Peng et al., 2015; Perez-Ruiz et al., 2015) .
UA and its anion urate represent the final breakdown product of the human purine degradation pathway. Sequential mutational events in the promoter and coding sequence first reduced and then abolished expression of Uro during the evolution of the hominid lineage ~15 million years ago (Johnson et al., 2011; Oda et al., 2002) . Hence, in contrast to many other animals humans are unable to enzymatically convert UA to the better water soluble product allantoin. While many mammals show serum UA levels of 1 mg/dl and lower, humans typically settle in a range of 4 -6 mg/dl, close to the UA solubility limit of 6.8 mg/dl at physiological pH and body temperature (Grassi et al., 2013) . Co-aligning with the expression pattern of the UA producing xanthine dehydrogenase the liver, as well as small and large intestine represent the main sites of UA production in the human body (Thul et al., 2017) . While circulating UA is freely filtered at the renal glomerulus usually 95 -99% of this fraction is reabsorbed in the proximal renal tubule via transporters such as URAT1 (SLC22A12) or GLUT9 (SLC2A9) and brought back into circulation (Enomoto et al., 2002; Vitart et al., 2008) .
Despite the impact of elevated UA in several disease processes, there has been a relative lack of new therapeutics, in part because of a lack of good animal models through which to explore key mechanisms underlying UA accumulation and its sequelae. Consequently, we designed a Drosophila melanogaster model to study the impact of rising UA levels in a genetic and dietary tractable model organism recapitulating both aspects encountered in hominoid evolution: depletion of urate oxidase activity combined with the changes in dietary habits. This system paved the way to determine previously unaccounted, aging relevant modulators to reduce UA and associated pathologies.
Results and Discussion:
Uro knockdown shortens lifespan and causes UA accumulation in a diet-dependent manner in Drosophila Unlike humans, Drosophila melanogaster uses the enzyme urate oxidase to convert UA into allantoin (Fig. S1A ). Therefore, we "humanized" a population of Drosophila to recapitulate the lack of functional urate oxidase making UA the end-product of purine catabolism. We used the heterologous, ligand (RU486)-induced gene switch system to generate spatially and temporally precise RNAi-mediated knockdown of Uro in Drosophila (McGuire et al., 2004) . Uro knockdown was initiated in 2-3 day-old flies using the ubiquitous daughterless gene switch driver ( Fig. S1B ).
Compared to isogenic control flies, Uro knockdown animals (Uro-RNAi #1) showed a dietdependent shortening of lifespan ( Fig. 1A) . Specifically, Uro-RNAi flies fed diets containing yeast concentrations above 2% died sooner, on average. The peak effect was observed for those fed a 5%-containing high yeast (HY) diet (Fig. 1B) . The diet-dependent lifespan attenuation was further confirmed using a second Uro targeting RNAi, and alternative ubiquitous (Da-GAL4) or Malpighian tubule-specific (c42-GAL4, Uro-GAL4) knockdown of Uro ( Fig. S1B -S1F), with the latter being the main tissue expressing Uro (Chintapalli et al., 2007) . As a negative control, knockdown of Uro using the neuronal Elav-GAL4 driver, i.e., in a tissue devoid of Uro expression, failed to show any effect ( Fig. S1E, S1F ). Of note, consistent with the concept that caloric restriction can extend lifespan in various species (López-Otín et al., 2016; Soultoukis and Partridge, 2016) our control and knockdown flies are significantly longer lived on low nutrient diets with 0.5% and 1% yeast extract compared to diets with a higher yeast extract content ( Fig. 1B, S1D ).
Next, using Uro knockdown flies the metabolomic profiling verified the expected elevation of UA levels accompanied by a diminished allantoin production ( Fig. 1C ). Also, an unbiased micro-CT scan revealed radiopaque masses (putative 'concretions') specifically in the abdominal area of Uro knockdown flies, but not in the control population ( Fig. S2A , Movie S1, S2). This observation was further substantiated by optical microscopy of dissected animals revealing the presence of concretions in the Malpighian tubule and hindgut of Uro knockdown flies ( Fig. 1D,   S2B ). Due to the restricted expression pattern of the Uro gene to the excretory system both the Malpighian tubule and the hindgut represent the anatomical sites where UA is most likely expected to accumulate. Metabolomic analyses of isolated concretions confirmed UA as the predominant component, accounting for 95% of the metabolites measured ( Fig. 1E, 1F , S2D).
We also found enhanced UA aggregation (i.e., a high proportion of flies with UA concretions) with increasing age (Fig. 1G ) and increasing dietary yeast content ( Fig. S2C ). Both effects match with the age-and diet-dependent occurrence of gout or uric acid kidney stones in humans (Doherty, 2009; Lieske et al., 2014) . Consistent with the reduced lifespan phenotype, UA concretion formation was also observed when using other ubiquitous (Da-GAL4) and
Malpighian tubule-specific (c42-GAL4, Uro-GAL4) Uro knockdown strains, but not in the neuronal-specific (Elav-GAL4) Uro knockdown strain (Fig. S2E ).
The dietary purine content mediates the lifespan and concretion phenotypes of Uro knockdown flies
To determine what component of the HY diet triggered increased UA production and associated phenotypes, we systematically supplemented the 'benign' low yeast diet (LY; 0.5% yeast content) with various basic nutrient groups: purines, pyrimidines, proteins, or sugar. We found that purines (metabolic precursors of UA), but not pyrimidines, proteins, or sugar led to a dosedependent shortening of lifespan and concretion formation ( Fig. 2A, 2B, S3 ). Purine homeostasis is controlled through orchestrated steps involving de novo synthesis, salvage, and degradation of purine intermediates (Fig. S4 ). The drug allopurinol, commonly used in the treatment of gout in humans, inhibits purine degradation by inhibiting xanthine dehydrogenase (XDH), an enzyme that converts hypo-/xanthine to urate. On the one hand, adding allopurinol to the HY diet rescued both the reduced lifespan and concretion formation in Uro knockdown flies ( Fig. 2C , 2D, S5A, S5C), thus, supporting the validity of our translational model for UA based pathologies. On the other hand, inhibiting purine synthesis by adding methotrexate (inhibits folate biosynthesis) also rescued the phenotypes of Uro knockdown flies, suggesting an important role for purine de novo synthesis in UA homeostasis ( Fig. 2E , 2F, S5B, S5C).
Similarly, genetically knocking-down the targets inhibited by methotrexate or allopurinol, dihydrofolate reductase (DHFR) or XDH, in addition to Uro, significantly reduced UA concretion formation ( Fig. S5D ).
The transcription factor FOXO dampens concretion formation by reducing UA levels and ROS formation.
Next, with the Drosophila model at hand other potential genes involved in purine metabolism that might be targeted to control UA production were examined. This is of interest given, that (a) commonly prescribed medications such as allopurinol can result in serious adverse drug reactions and (b) common genetic variations identified to date explain only 6% of the variance encountered in serum UA levels, and consequently these genes might not represent ideal targets to lower the metabolic UA load (Hassan et al., 2011; Kinder et al., 2005; Reginato et al., 6 2012; Yang et al., 2010) . To identify previously unrecognized regulators of UA metabolism, we examined the ILS pathway for two reasons. Firstly, ILS is a conserved signaling cascade activated when Drosophila is fed a HY diet (Britton et al., 2002; Broughton and Partridge, 2009; Russell and Kahn, 2007; Teleman, 2010) . Secondly, a recent genome-wide association study identified polymorphisms in the human ILS gene IGF1R that were associated with serum UA concentration (Köttgen et al., 2013) . Thus, we examined components of the ILS pathway for potential targets for future therapies to control UA production. Yet, the translational potential of the above findings relies on there being a conserved mechanism between Drosophila and humans that relates the ILS pathway and UA levels. We assessed whether single nucleotide polymorphisms (SNPs) in different genes of the ILS pathway are associated with either UA levels or gout. Using data from humans (Tab. S1), we found that SNPs in the AKT2 and FOXO3 genes were associated with either UA levels or the incidence for gout ( Fig. 3D , Tab. S2). These data support the idea that some constituents of the ILS signaling network, including the downstream transcription factor FoxO, play a critical and conserved role in affecting UA levels and associated pathology in both flies and humans.
Lifespan attenuation and UA concretion formation of Uro knockdown flies are triggered by NOX mediated ROS production
We next addressed the underlying mechanism of the link between the ILS pathway and UA levels. UA has been proposed to play several physiological roles, depending on where it is acting. For instance, UA can act as an antioxidant in the blood, where it accounts for up to 60% of the antioxidative capacity (Maiuolo et al., 2016) . In turn, in an intracellular setting such as in adipocytes, UA is considered a prooxidant and proinflammatory molecule (Imaram et al., 2010; Kanbay et al., 2016; Sautin and Johnson, 2008) . Consistent with this, Uro knockdown flies showed elevated ROS production (prooxidative action) in the cells of the Malpighian tubule and hindgut accommodated by increased antimicrobial peptide expression (proinflammatory action).
Both phenotypes could be reduced by FOXO over-expression ( Fig. 3E1, 3E2 , S6A-C).
However, depleting the NFκB transcription factor paralogs (Relish, Dorsal, and Dif), whose 7 function enhances expression of antimicrobial peptides, did not significantly diminish concretion formation ( Fig. 3B ). Therefore, it is likely that in the fly model the proinflammatory action secondary to Uro knockdown represents a downstream effect of UA, as seen in mammals (Lu et al., 2015; Lyngdoh et al., 2011) , but does not itself cause any further elevation in UA levels.
The observed increase of ROS levels secondary to Uro knockdown ( Fig. 3E2, S6A ) could stem from two sources: (1) inefficient expression of ROS combating genes, or (2) an overabundance of ROS-producing enzymes. From the eleven oxidative stress-related genes whose expression was examined in the Uro knockdown flies only the ROS-producing NADPH Oxidase (NOX) showed significantly higher mRNA content ( Fig. 4A, S6D ). This increase in NOX expression was significantly abolished by FOXO over-expression ( Fig. 4A ). More directly, we also found that genetic ablation of NOX expression via RNAi countered both the short lifespan and concretion formation characteristically observed in Uro knockdown flies ( Fig. 4B , 4C, S7). As with FOXO over-expression, knocking down NOX expression in Uro knockdown flies significantly reduced UA accumulation ( Fig. 4D ). We saw a similar result after pharmacologically inhibiting NOX activity and the associated ROS production using either apocynin (ACY; a NOX inhibitor) or vitamin C (Vit C; a ROS scavenger), respectively. Both treatments reversed the shortened lifespan and reduced concretion formation in a dose-dependent manner ( Fig. 4E, 4F , S8A-C).
While vitamin C seemed to extend the lifespan of both the control and Uro knockdown flies, the impact of apocynin on lifespan was specific for the urate oxidase depleted animals ( Fig. 4E ).
Importantly, the transgenic FOXO or NOX manipulations did not alter the efficiency of Uro mRNA depletion, which argues for the direct impact of the FOXO and NOX gene products on UA level (Fig. 4A , the three bars to the left). Both alternatives over-expression of genes encoding for ROS-combating enzymes, such as cytosolic or mitochondrial superoxide dismutase (SOD1, SOD2), or treatment with the water-soluble vitamin E derivate Trolox failed to prevent UA concretion formation ( Fig. S8C, S8D ), and hence also argue for the direct involvement of NOX in modulating UA levels.
Conclusion:
Our studies argue the importance of purines as an important dietary component that limits lifespan. Generally, mutants in genes that influence lifespan upon dietary restriction either extend lifespan upon rich nutrient conditions while failing to extend lifespan upon dietary restriction conditions or attenuate the maximum lifespan upon dietary restriction. However, Uro mutants belong to a "novel" class of genes that limit lifespan only upon rich conditions but have 8 little or no influence upon dietary restriction. We hypothesize that mutants that display such a phenotype encode a gene that amplifies the cellular damage that takes place under rich nutrient conditions compared to dietary restriction. We speculate that the increase of UA is deleterious and a lower UA level is partially responsible for the lifespan extension upon dietary restriction.
Our results also highlight the importance of ILS signaling, and its downstream effector NOX, as an important mediator of UA metabolism and related pathologies (Fig. 4G) . Given the overnutrition encountered in developed countries, the causal nexus uncovered here identifies potential new drug targets that could help regulate UA levels, ameliorating pathologies associated with hyperuricemia and extending human health-span.
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Material and Methods:

Contact for reagent and resource sharing
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Pankaj Kapahi (pkapahi@buckinstitute.org).
Experimental model and subject details
Fly strains used in this study
Fly strains purchased from Bloomington Drosophila Stock Center are indicated by the prefix "b", strains from FlyORF, Zurich by "F", strains from NIG-Fly, Mishima by "n", and strains from VDRC, Vienna by "v". 
Fly husbandry, dietary and pharmacological manipulations
All fly lines were maintained on standard fly yeast extract medium containing 1.5% yeast, 5% sucrose, 0.46% agar, 8.5% of corn meal, and 1% acid mix (a 1:1 mix of 10% propionic acid and 83.6% orthophosphoric acid) prepared in distilled water. To prepare the media, cornmeal (85 g), sucrose (50 g), active dry yeast (16 g, "Saf-instant") and agar (4.6 g) were mixed in a liter of water and brought to boil under constant stirring. Once cooled down to 60°C 10 ml of acid mix was added to the media. The media were then poured in vials (~10 ml/ vial) or bottles (50 ml/bottle) and allowed to cool down before storing at 4°C for later usage. These vials or bottles were then seeded with some live yeast just before the flies are transferred and used for maintenance of lab stocks, collection of virgins, or setting up crosses.
Experimental low and high yeast diets varied only with regard to the yeast type and content ranging from 0% to 8%. Diets declared as LY (low yeast content) and HY (high yeast content) contained 0.5% and 5% Baker's yeast extract (#212750 BactoTM Yeast Extract, B.D.
Diagnostic Systems, Sparks, MD), respectively. If not stated otherwise pharmacological treatments or dietary supplementations were mixed with the other ingredients during preparation of the food. As for the standard medium, the mix was brought to a boil under constant stirring and allowed to cool down to 60°C before adding the acid mix. For the induction of transgenic elements via the GAL4-UAS system when using a gene switch driver 200 μM RU486 (Mifepristone, Sigma) in 100% ethanol was added to the food while the isogenic controls received vehicle treatment. The media was then poured in vials (~5 ml/vial) and allowed to cool down before storing at 4°C for later usage.
The dietary supplementations and drug treatments used were as follows: Flies were kept in the stock bottles for five days, after which the parents were removed, and the larvae could develop in a temperature (25°C) and humidity (60%) controlled designated fly room with a 12-hour light / dark cycle. Newly eclosed flies could mate for 2 -3 days, to complete development post-eclosion, before they were grouped under light CO 2 anesthesia. Sorted females were then transferred to the appropriate media vials for subsequent analyses.
Method details
Lifespan Analysis
Flies developed on standard fly 1.5% yeast extract medium were transferred to the necessary diet within 72 hours after eclosion. For survivorship analysis four to six media containing vials with 25 mated females were kept in a temperature (25°C) and humidity (60%) controlled designated fly room with a 12-hour light / dark cycle. Every other day flies were transferred to fresh food and fly survival was scored by counting the number of dead flies. The significance of change was determined using the log-rank test.
Dissection and scoring of concretion formation
For dissection and imaging assays adult female flies were dissected after 4, 7, 11, or 14 days. For the micro-computer tomography (µCT) imaging fly specimens were scanned in 50% ethanol using a micro-XCT unit at 4X magnification (4.5 µm/voxel) with 1200 image projections.
Scanning was performed with a 3 second exposure, source power of 40 W, 200 µA current, source distance of ~30 mm, detector distance of ~14 mm, camera binning 2, and an angle sweep from -93° to 93°. Post-3D reconstruction, the acquired data was further processed and analyzed with Avizo software (Version 9.3.0; FEI, Hillsboro, Oregon).
Collection of deposits for mass spectrometry-based metabolomics
Flies were dissected in 50% methanol/water mix and the deposits from the hindgut area were isolated using fine forceps. Deposits of 25 flies carrying concretions were collected in an Eppendorf tube filled with 500 µl 50% methanol/water. The material was sedimented by centrifugation for 15 s with 5,000 rpm and the supernatant was aspirated. After two further wash steps with 500 µl 50% methanol/water deposits were frozen in liquid nitrogen and stored at -80°C until further processing.
High-performance liquid chromatography (HPLC) mass spectrometry (MS)
High-performance liquid chromatography (HPLC) was performed using an Agilent 1260 times over a period of ~30 min (each 1 min long). Subsequently, the samples were centrifuged at 10,000 rpm for 10 min, the supernatant was filtered, and 3 μl of each was injected for HPLC-MRM analysis (vide infra) without any additional processing. For the analysis of fly deposits, samples were collected as described above and prepared for HPLC-MRM analysis (vide infra)
as described above for whole flies.
Optimization of analyte-specific MRM transitions, such as determination of suitable precursor and product ions and optimal MS parameters for each transition (Q1, precursor → Q3, product)
were achieved by isocratic flow injection of the 1-10 μM solution (final) for each standard, diluted in 80% methanol. The most intense transition was used as quantifier, whereas one or more additional transitions were used as qualifier for each compound (Tab. S3). A final standard mixture of all compounds at 5 µM (containing the internal standard 2-chloroadenosine at 2.5 µM), were prepared prior to analysis and injected at the onset of each biological sample set.
Based on previous reports (Yuan et al., 2012), the following HPLC program was developed: a solvent gradient of 20 mM ammmonium acetate + 20 mM ammonium hydroxide (pH=~9.5) + 5% acetonitrile (aqueous) -acetonitrile (organic) was used with 0.4 ml/min flow rate, starting with an acetonitrile content of 85% for 1 min, which was decreased to 30% over 3 min and then to 0% over 7 min and held at 0% for 2 min. The HPLC column was subsequently reconstituted to its initial condition (acetonitrile content of 85%) over the next 1 min and re-equilibrated for 7 min.
Metabolome ex-tracts from whole flies or deposits were analyzed by HPLC-MRM with positive/negative switching of source ion modes (Yuan et al., 2012) . Source conditions were as follows: curtain gas (CUR) 20, collision gas (CAD) 7, ion source gas 1 (GS1) 30, ion source gas 2 (GS2) 30, ionspray voltage (IS) ±4500 V, and source temperature (TEM) 450°C.
Quantification was based on integration of analyte-specific peaks obtained from HPLC-MRM runs.
Dihydroethidium (DHE) staining for ROS measurements
Intact guts with adhering Malpighian tubules were dissected from female flies in a droplet of PBS (137 mM NaCl, 2.7 mM KCl, 10 mM Phosphate, pH 7.4) on ice and subsequently stained for 5 min with 45 µM DHE (Thermo Fisher Scientific) dissolved in DMSO (Sigma Aldrich). After three 10 min wash steps with PBS the sample was fixed for 45 min using 4% formaldehyde (Sigma Aldrich) in PBS followed by another three 10 min wash steps. After a 15 min staining with 1 µg/ml DAPI (Thermo Fisher Scientific) dissolved in PBS the specimen was mounted onto a microscope slide using Mowiol (Sigma Aldrich). Confocal images were collected using a Zeiss 1 µg of total RNA in a volume of 16 µl was used per sample and cDNA was synthesized using 4 µl iScript Reverse Transcription Supermix for RT-qPCR (Bio-Rad) according to the manufacturer's protocol. The RT-PCR reaction protocol included a priming step (5 min at 25°C) followed by the reverse transcription (30 min at 42°C) and inactivation of the reaction (5 min at 85°C). If necessary, cDNA was stored at -20°C before the quantitative real-time PCR.
Quantitative real-time PCR (qPCR)
Using 3 µl of the 1:10 diluted cDNA as a template, 2 µl of a primer pair (500 nM each) and 5 µl (Wen et al., 2015) . The study population consisted of 80,795 adult subjects of European ancestry. The average age of the cohort was approximately 63 years old at the time of sample collection for genotyping. Two phenotypes were used for this study: (1) Gout, defined as two ICD-9 codes for gout in the electronic health record; (2) mean serum UA levels. Association analyses were conducted using linear or logistic regression models in PLINK v1.90 adjusting for population structure using the top 10 principal components. In the model, concomitant diuretics and gender were included as covariates because of their strong 21 correlation with all phenotypes. Maximum body mass index (BMI) correlated strongly with UA levels, and was therefore also included as a covariate in all analyses.
SNPs within +/-2kb of ILS genes (FOXO1, FOXO3, AKT1, AKT2, AKT3, PTEN) were analyzed.
Lists of SNPs within genes were analyzed using NIH LDLink SNPclip tool (Machiela and Chanock, 2015) , where SNPs in high linkage disequilibrium (R 2 >0.5) were pruned. Genespecific p-value thresholds were set as 0.05/(2 phenotypes*number of SNPs in each gene postpruning). As a quality control step, top associated SNPs were checked for extreme HWE departures in our samples.
R v3.4.0 was used to create phenotypes and analyze associations between risk factors and phenotypes.
Quantification and statistical analysis
Bar graphs and scatter blots represent the mean ± standard error of the mean (SEM), when indicated. Lifespan curves, and other graphs were visualized using GraphPad Prism 5 software.
For statistical comparisons between the control and single treatment group a two-tailed student's t-test was used; except for lifespan analysis where the log-rank test was performed.
When multiple conditions were compared against one control group ANOVA was used. 
